Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Lung
Erschienen in: Lung 4/2019

12.06.2019 | INTERSTITIAL LUNG DISEASE

How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants

verfasst von: Manuel Ramos-Casals, Belchin Kostov, Pilar Brito-Zerón, Antoni Sisó-Almirall, Robert P. Baughman, the Autoimmune Big Data Study Group

Erschienen in: Lung | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Sarcoidosis is a systemic disease in which the personal environment seems to drive a differentiated disease frequency and clinical expression. The main epidemiological studies suggest a key influence of potential environmentally linked exposures related to the type of occupation, the household, life style, socioeconomic status, and region of residence.

Objective

To provide an update on how sarcoidosis may be modulated by environmental factors.

Data Sources

We searched PubMed for epidemiological studies.

Synthesis

The risk of sarcoidosis is enhanced in people working in jobs related to agriculture, water, construction, metal machining, education, and health, and reduced in those working in jobs mainly centered on personal care. Studies have confirmed seasonal-related peaks of sarcoidosis incidence that follow geographical North–South and West–East gradients. Other personal factors include smoking, personal household exposures, and leisure activities. The evidence pointing to the crucial role of the environment in the etiopathogenesis of sarcoidosis is mounting rapidly. Few diseases so strongly combine geography, environment, gender, and ethnicity as key etiopathogenic factors, with susceptibility to any putative agent being modulated by the individual exposome and genome.

Conclusion

Geoepidemiological research should focus on evaluating the combined effects of environmental and genetic factors, the identification of clusters of geographically driven exposures, and more precise measurement of all personal exposures (degree of combination, length, and level of exposure).
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Baughman RP, Lower EE, du Bois RM (2003) Sarcoidosis. Lancet (Lond, Engl) 361(9363):1111–1118CrossRef
2.
3.
4.
Pereira CAC, Dornfeld MC, Baughman R, Judson MA (2014) Clinical phenotypes in sarcoidosis. Curr Opin Pulm Med 20(5):496–502CrossRefPubMed
5.
Dubrey S, Shah S, Hardman T, Sharma R (2014) Sarcoidosis: the links between epidemiology and aetiology. Postgrad Med J 90(1068):582–589CrossRefPubMed
6.
Ramos-Casals M et al (2015) Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev 14(8):670–679CrossRefPubMed
7.
Poukkula A, Huhti E, Lilja M, Saloheimo M (1986) Incidence and clinical picture of sarcoidosis in a circumscribed geographical area. Br J Dis Chest 80(2):138–147CrossRefPubMed
8.
Putkonen T, Hannuksela M, Mustakallio KK (1966) Cold season prevalence of the clinical onset of sarcoidosis. Arch Environ Health 12(5):564–568CrossRefPubMed
9.
Gupta D, Agarwal R, Aggarwal AN (2013) Seasonality of sarcoidosis: the ‘heat’ is on…. Sarcoidosis Vasc Diffus Lung Dis 30(3):241–243
10.
Wilsher ML (1998) Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur Respir J 12(5):1197–1199CrossRefPubMed
11.
Glennas A et al (1995) Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol 34(1):45–50CrossRefPubMed
12.
13.
Henke CE, Henke G, Elveback LR, Beard CM, Ballard DJ, Kurland LT (1986) The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol 123(5):840–845CrossRefPubMed
14.
Gonzalez SF, Gonzalez RL (2011) Epidemiology, presentation forms, radiological stage and diagnostic methods of sarcoidosis in the area of Leon (2001-2008). Rev Clin Esp 211(6):291–297CrossRef
15.
Badrinas F et al (1989) Sarcoidosis in Catalonia: analysis of 425 cases. Med Clin (Barc) 93(3):81–87
16.
Demirkok SS, Basaranoglu M, Coker E, Karayel T (2007) Seasonality of the onset of symptoms, tuberculin test anergy and Kveim positive reaction in a large cohort of patients with sarcoidosis. Respirology 12(4):591–593CrossRefPubMed
17.
Panayeas S, Theodorakopoulos P, Bouras A, Constantopoulos S (1991) Seasonal occurrence of sarcoidosis in Greece. Lancet (Lond, Engl) 338(8765):510–511CrossRef
18.
Hosoda Y et al (1976) A cooperative study of sarcoidosis in Asia and Africa: analytic epidemiology. Ann N Y Acad Sci 278:355–367CrossRefPubMed
19.
Deubelbeiss U, Gemperli A, Schindler C, Baty F, Brutsche MH (2010) Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur Respir J 35(5):1088–1097CrossRefPubMed
20.
Arkema EV, Grunewald J, Kullberg S, Eklund A, Askling J (2016) Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden. Eur Respir J 48(6):1690–1699CrossRefPubMed
21.
Newman LS et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170(12):1324–1330CrossRefPubMed
22.
Kieszko R et al (2016) The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings. Arch Med Sci 12(6):1263–1272CrossRefPubMed
23.
Alilovic M, Peros-Golubicic T, Tekavec-Trkanjec J, Smojver-Jezek S, Liscic R (2006) Epidemiological characteristics of sarcoidosis patients hospitalized in the University Hospital for Lung Diseases ‘Jordanovac’ (Zagreb, Croatia) in the 1997-2002 period. Coll Antropol 30(3):513–517PubMed
24.
Leza MA et al (2003) Sarcoidosis in a sanitary area at Leon (Spain). Epidemiology and clinical features. An Med Interna 20(12):617–620
25.
Buxbaum LA, Lackland DT, Judson MA, Hoel DG, Mohr LC Jr (2000) Geographic patterns of pulmonary disease in south carolina. Ann Epidemiol 10(7):460–461CrossRefPubMed
26.
Gupta D, Vinay N, Agarwal R, Agarwal AN (2013) Socio-demographic profile of patients with sarcoidosis vis-a-vis tuberculosis. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG 30(3):186–193
27.
Kajdasz DK, Lackland DT, Mohr LC, Judson MA (2001) A current assessment of rurally linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 11(2):111–117CrossRefPubMed
28.
Beghe D et al (2017) Sarcoidosis in an Italian province. Prevalence and environmental risk factors. PLoS ONE 12(5):6859CrossRef
29.
Pirozzi CS, Mendoza DL, Xu Y, Zhang Y, Scholand MB, Baughman RP (2018) Short-term particulate air pollution exposure is associated with increased severity of respiratory and quality of life symptoms in patients with fibrotic sarcoidosis. Int J Environ Res Public Health 15(6):1077CrossRefPubMedCentral
30.
Kajdasz DK, Judson MA, Mohr LCJ, Lackland DT (1999) Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. Am J Epidemiol 150(3):271–278CrossRefPubMed
31.
Werner E (1959) Boeck’s disease as an occupational disease. Tuberkulosearzt 13:780–785PubMed
32.
Seiler E (1960) On the epidemiology of sarcoidosis (Boeck’s disease) in Switzerland. Statistical research on the geographical and occupational distribution of 108 military patients with sarcoidosis. Schweizerische Zeitschrift fur Tuberkulose und Pneumonol Rev suisse la Tuberc Pneumonol Riv Svizz della Tuberc e della Pneumonol 17:205–228
33.
Prezant DJ et al (1999) The incidence, prevalence, and severity of sarcoidosis in New York City firefighters. Chest 116(5):1183–1193CrossRefPubMed
34.
Rossman MD et al (2008) HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG 25(2):125–132
35.
Kucera GP et al (2003) Occupational risk factors for sarcoidosis in African-American siblings. Chest 123(5):1527–1535CrossRefPubMed
36.
Barnard J et al (2005) Job and industry classifications associated with sarcoidosis in A Case-Control Etiologic Study of Sarcoidosis (ACCESS). J Occup Environ Med 47(3):226–234CrossRefPubMed
37.
Kreider ME et al (2005) Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 128(1):207–215CrossRefPubMed
38.
Jordan HT, Stellman SD, Prezant D, Teirstein A, Osahan SS, Cone JE (2011) Sarcoidosis diagnosed after September 11, 2001, among adults exposed to the World Trade Center disaster. J Occup Environ Med 53(9):966–974CrossRefPubMed
39.
Liu H et al (2016) Association between occupational exposures and sarcoidosis: an analysis from death certificates in the United States, 1988-1999. Chest 150(2):289–298CrossRefPubMedPubMedCentral
40.
Gorham ED, Garland CF, Garland FC, Kaiser K, Travis WD, Centeno JA (2004) Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel: a 27-year historical prospective study, 1975-2001. Chest 126(5):1431–1438CrossRefPubMed
41.
Crowley LE et al (2011) ‘Sarcoid like’ granulomatous pulmonary disease in World Trade Center disaster responders. Am J Ind Med 54(3):175–184CrossRefPubMed
42.
Bours S et al (2016) Risk of vertebral and non-vertebral fractures in patients with sarcoidosis: a population-based cohort. Osteoporos Int 27(4):1603–1610CrossRefPubMed
43.
Valeyre D et al (1988) Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax 43(7):516–524CrossRefPubMedPubMedCentral
44.
Hance AJ et al (1986) Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis. Ann N Y Acad Sci 465:643–656CrossRefPubMed
45.
Harf RA, Ethevenaux C, Gleize J, Perrin-Fayolle M, Guerin JC, Ollagnier C (1986) Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci 465:625–631CrossRefPubMed
46.
47.
Ungprasert P, Carmona EM, Utz JP, Ryu JH, Crowson CS, Matteson EL (2016) Epidemiology of sarcoidosis 1946-2013: a population-based study. Mayo Clin Proc 91(2):183–188CrossRef
48.
Krell W, Bourbonnais JM, Kapoor R, Samavati L (2012) Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis. Lung 190(5):529–536CrossRefPubMed
49.
Janot AC et al (2015) Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a New Orleans sarcoidosis population. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG 32(2):138–143
50.
Gupta D, Singh AD, Agarwal R, Aggarwal AN, Joshi K, Jindal SK (2010) Is tobacco smoking protective for sarcoidosis? A case-control study from North India. Sarcoidosis Vasc Diffus Lung Dis Off J WASOG 27(1):19–26
51.
Hattori T, Konno S, Shijubo N, Ohmichi M, Nishimura M (2013) Increased prevalence of cigarette smoking in Japanese patients with sarcoidosis. Respirology 18(7):1152–1157PubMed
52.
Cozier YC, Berman JS, Palmer JR, Boggs DA, Serlin DM, Rosenberg L (2011) Sarcoidosis in black women in the United States: data from the Black Women’s Health Study. Chest 139(1):144–150CrossRefPubMed
53.
Gvozdenovic BS et al (2013) Effect of obesity on patient-reported outcomes in sarcoidosis. Int J Tuberc Lung Dis 17(4):559–564CrossRefPubMed
54.
Rodrigues MM, Coletta ENAM, Ferreira RG, de Pereira CAC (2013) Delayed diagnosis of sarcoidosis is common in Brazil. J Bras 39(5):539–546
55.
Rabin DL, Richardson MS, Stein SR, Yeager HJ (2001) Sarcoidosis severity and socioeconomic status. Eur Respir J 18(3):499–506CrossRefPubMed
56.
Westney GE, Judson MA (2006) Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 27(3):453–462 vi CrossRefPubMed
57.
Newman LS (2005) Aetiologies of sarcoidosis. In: Drent M, Costabel U (eds) Sarcoidosis. European Respiratory Society, Lausanne, pp 23–48
58.
Parkes SA, Baker SB, Bourdillon RE, Murray CR, Rakshit M (1987) Epidemiology of sarcoidosis in the Isle of Man–1: a case controlled study. Thorax 42(6):420–426CrossRefPubMedPubMedCentral
59.
60.
Esteves T, Aparicio G, Garcia-Patos V (2016) Is there any association between Sarcoidosis and infectious agents?: A systematic review and meta-analysis. BMC Pulm Med 16(1):165CrossRefPubMedPubMedCentral
61.
Rybicki BA et al (2001) Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164(11):2085–2091CrossRefPubMed
62.
63.
64.
Baughman RP et al (2016) Sarcoidosis in America. Analysis based on health care use. Ann Am Thorac Soc 13(8):1244–1252CrossRefPubMed
65.
66.
Rossman MD, Kreider ME (2007) Lesson learned from ACCESS (A Case Controlled Etiologic Study of Sarcoidosis). Proc Am Thorac Soc 4(5):453–456CrossRefPubMed
67.
Rybicki BA, Iannuzzi MC (2007) Epidemiology of sarcoidosis: recent advances and future prospects. Semin Respir Crit Care Med 28(1):22–35CrossRefPubMed
Metadaten
Titel
How the Frequency and Phenotype of Sarcoidosis is Driven by Environmental Determinants
verfasst von
Manuel Ramos-Casals
Belchin Kostov
Pilar Brito-Zerón
Antoni Sisó-Almirall
Robert P. Baughman
the Autoimmune Big Data Study Group
Publikationsdatum
12.06.2019
Verlag
Springer US
Erschienen in
Lung / Ausgabe 4/2019
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-019-00243-2

Weitere Artikel der Ausgabe 4/2019

Lung 4/2019 Zur Ausgabe

INTERSTITIAL LUNG DISEASE

Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis

INTERSTITIAL LUNG DISEASE

Sarcoidosis and Work Participation: The Need to Develop a Disease-Specific Core Set for Assessment of Work Ability

ASTHMA

A Meta-analysis of Diagnostic Test Agreement Between Eucapnic Voluntary Hyperventilation and Cardiopulmonary Exercise Tests for Exercise-Induced Bronchoconstriction

SLEEP

C-Reactive Protein Levels and the Risk of Incident Cardiovascular and Cerebrovascular Events in Patients with Obstructive Sleep Apnea

Interstitial Lung Disease

Impact of Psychological Deficits and Pain on Physical Activity of Patients with Interstitial Lung Disease

SLEEP

Predicting Obstructive Sleep Apnea in Patients with Insomnia: A Comparative Study with Four Screening Instruments

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise